Scott L Letendre Selected Research

Scott L Letendre Research Topics

Disease

23	HIV Infections (HIV Infection) 01/2022 - 06/2010
19	Neurocognitive Disorders (Clerambault Syndrome) 10/2021 - 02/2008
15	Inflammation (Inflammations) 01/2022 - 06/2010
8	Acquired Immunodeficiency Syndrome (AIDS) 12/2019 - 05/2002
7	Cognitive Dysfunction 01/2022 - 09/2004
7	Infections 12/2016 - 01/2004
4	Coinfection 04/2016 - 04/2010
3	Substance-Related Disorders (Drug Abuse) 01/2019 - 11/2009
3	Gliosis 10/2018 - 12/2006
3	Dementia (Dementias) 04/2016 - 05/2002
3	Hepatitis C 02/2014 - 10/2005
2	Polyneuropathies (Polyneuropathy) 01/2022 - 04/2009
2	Neuralgia (Stump Neuralgia) 01/2022 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 11/2015
2	Brain Injuries (Brain Injury) 04/2021 - 05/2015
2	Neuroinflammatory Diseases 11/2020 - 12/2016
2	Anemia 04/2016 - 02/2014
2	Malaria 09/2012 - 11/2009
1	Premature Aging 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Pain (Aches) 01/2022
1	Viremia 10/2021
1	Invasive Fungal Infections 01/2021
1	Frailty 11/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Amyloid Plaque 10/2018
1	Cerebral Small Vessel Diseases 10/2018
1	Vascular Remodeling 02/2017
1	Encephalitis (Encephalitis, Rasmussen) 01/2017
1	Leukocytosis (Pleocytosis) 04/2016
1	Disease Progression 01/2016
1	Pharyngitis (Sore Throat) 10/2014
1	Vision Disorders (Hemeralopia) 01/2014
1	Mood Disorders (Mood Disorder) 12/2013
1	Neurobehavioral Manifestations 12/2013
1	Bipolar Disorder (Manic Depressive Psychosis) 12/2013
1	Vascular Diseases (Vascular Disease) 04/2010
1	Liver Diseases (Liver Disease) 10/2005
1	Leukoencephalopathies 05/2002

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2010
10	Methamphetamine (Desoxyn)FDA LinkGeneric 11/2019 - 01/2004
9	RNA (Ribonucleic Acid)IBA 11/2020 - 11/2009
5	Pharmaceutical PreparationsIBA 12/2020 - 09/2007
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2009
4	Biological ProductsIBA 04/2021 - 10/2005
4	Proteins (Proteins, Gene)FDA Link 07/2015 - 04/2010
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 11/2015
2	NeopterinIBA 01/2022 - 01/2016
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022 - 10/2005
2	Lipopolysaccharide ReceptorsIBA 01/2019 - 05/2015
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2022
1	Transferrin (beta 2 Transferrin)IBA 10/2021
1	C-Reactive ProteinIBA 01/2021
1	Homovanillic AcidIBA 11/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	Pain-FreeIBA 01/2020
1	fibrin fragment D (D-dimer)IBA 01/2019
1	TESIBA 01/2019
1	Tenofovir (Viread)FDA Link 10/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017
1	Angiopoietin-2IBA 02/2017
1	Immunoglobulin G (IgG)IBA 12/2016
1	Zidovudine (Retrovir)FDA LinkGeneric 04/2016
1	FHDIBA 01/2016
1	Tryptophan (L-Tryptophan)FDA Link 01/2016
1	Protons (Proton)IBA 05/2015
1	Integrase InhibitorsIBA 07/2014
1	CytokinesIBA 07/2014
1	Retinaldehyde (Retinal)IBA 01/2014
1	AntibodiesIBA 09/2012
1	Cysteine (L-Cysteine)FDA Link 04/2012
1	Hepatitis C AntibodiesIBA 06/2011
1	Antiviral Agents (Antivirals)IBA 02/2011
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 04/2010
1	ApolipoproteinsIBA 04/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2005
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2005
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2004

Therapy/Procedure

20	Therapeutics 01/2022 - 05/2002
16	Highly Active Antiretroviral Therapy (HAART) 12/2021 - 05/2002
8	Art Therapy 01/2022 - 02/2011
4	Activities of Daily Living (ADL) 01/2020 - 07/2010
1	Pain Management 01/2022